•Research progress in molecular targeted therapy for inflammatory bowel disease
•Extracellular vesicles derived from Kaempferia Galanga L. show promise for targeted oral therapy in the treatment of ulcerative colitis
•A narrative review on the frequency, pathophysiology and management of bowel urgency associated with ulcerative colitis
•Cutting edge developments and novel targets in IBD: Microbiome in IBD
•A comprehensive guide to intestinal ultrasound in ulcerative colitis